Pricing Log in Create free account

Alector, Inc. (ALEC) vs Galectin Therapeutics Inc. (GALT)

Alector, Inc. and Galectin Therapeutics Inc. are both Biotechnology companies. Alector, Inc. and Galectin Therapeutics Inc. are of similar size ($309.9M and $301.0M). Galectin Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Alector, Inc. trades at 6.6×. Alector, Inc. has the higher net margin (23.9% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Alector, Inc. leads on 7 and Galectin Therapeutics Inc. on 5.

Valuation

Metric ALEC GALT Biotechnology median
P/E 6.57 n/m 10.60
P/S 1.49 n/m 9.40
P/B 2.22 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.80 n/m 9.02
Earnings yield 15.22% (13.69%) (32.88%)
Free cash flow yield (58.00%) (7.68%) (23.13%)

Profitability

Metric ALEC GALT Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 20.16% 0.00% 0.00%
Net margin 23.87% 0.00% 0.00%
Free cash flow margin (86.40%) 0.00% 0.00%
Return on equity 47.52% 21.69% (51.96%)
Return on assets 16.53% (184.22%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALEC GALT Biotechnology median
Revenue growth (TTM) 151.23% — 6.76%
EPS growth (last fiscal year) (13.01%) 36.84% 29.88%
Revenue growth, 5-year CAGR (0.05%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALEC GALT Biotechnology median
Debt to equity 0.00 (0.76) 0.00
Current ratio 4.10 0.10 4.97
Net debt to EBITDA 1.61 (5.79) 1.01

Dividend

Metric ALEC GALT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALEC GALT Biotechnology median
Market cap 309.86m 301.04m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack